Analyst stock forecast
Biogen Forecast: $238.18 Analyst Target
Direct answer
Biogen's average price target is $238.18.
The target implies +9.5% from the recorded current price, and the consensus rating is Buy.
The low target implies -19.5%, the high target implies +38%, and the range spans 57.5% of the current price.
Forecast evidence checked September 18, 2026.
Get free Biogen email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $217.45
- Average price target
- $238.18
- High price target
- $300.00
- Low price target
- $175.00
- Low target gap
- -19.5%
- Target upside
- +9.5%
- High target gap
- +38%
- Target range width
- 57.5%
- Consensus rating
- Buy
- Analysts
- 31
- Evidence date
- September 18, 2026
- Valid through
- September 25, 2026
Explore related company data
Read the frequently asked questions.
What is Biogen's average price target?
Biogen's verified average price target is $238.18. The target range is $175.00 to $300.00.
How far are Biogen's low and high targets from the recorded price?
The low target implies -19.5%, while the high target implies +38%.
How many analysts are included in Biogen's consensus?
The verified consensus includes 31 analysts.
How is Biogen's target upside or downside calculated?
The average target of $238.18 is divided by the recorded price of $217.45, then one is subtracted to produce +9.5%. This does not guarantee a future return.
When was Biogen's analyst forecast verified?
The data was verified on 2026-09-18. The dataset is valid through 2026-09-25.